《Recent Advances in Cancer Research and Therapy（癌症研究及其治療的最新進展）》是2013年清華大學出版社出版的圖書，作者是劉新垣、（美）帕斯卡、時玉舫。
基本介紹
- 書名：Recent Advances in Cancer Research and Therapy（癌症研究及其治療的最新進展）
- 作者：劉新垣、（美）帕斯卡、時玉舫
- 出版社：清華大學出版社
- 出版時間：2013年8月14日
- 定價：198 元
- 裝幀：精裝
- ISBN：9787302326304
內容簡介,圖書目錄,
內容簡介
《癌症研究及其治療的最新進展》集全球癌症研究與治療領域的高水平專家集體之力，全面介紹了目前癌症領域的最新研究進展。內容包括：生物治療的研究和套用的詳細描述，超級干擾素的抗癌作用；抗體治療、免疫治療、腫瘤幹細胞研究，化學治療的研究和套用的介紹；細胞治療（特異性及非特異性）；中藥臨床和三氧化砷治療白血病；對全球發病率最高的肺癌、腸癌的研究，針對中國癌症發病率特別高的食道癌、鼻咽癌的研究等。
《癌症研究及其治療的最新進展》的讀者對象為所有從事癌症研究與治療的專家、研究生、大學生。
圖書目錄
Preface
List of Contributors
1 Cancer Biotherapy: Progress in China
2 Cancer Targeting Gene-Viro-Therapy and Its PromisingFuture
3 Relationship Between Antiproliferative Activities and Class IMHC Surface Expression of Mouse Interferon Proteins on B16-Fl0Melanoma Cells
4 Mitotic Regulator Hecl as a Potential Target for CancerTherapy
5 Advances in Liposome-Based Targeted Gene Therapy of Cancer
6 Rewiring the Intracellular Signaling Network in Cancer
7 Research and Development of Highly Potent Antibody-Based DrugConjugates and Fusion Proteins for Cancer Therapy
8 Cancer Stem Cell
9 p53: A Target and a Biomarker of Cancer Therapy?
10 Recombinant Adenoviral-p53 Agent （Gendicine）: QualityControl, Mecharusm of Action, and Its Use for Treatment ofMalignant Tumors
11 Three-Dimensional Tumor Model and T-Lymphocytes Immunotherapyfor Cancer
12 Advances in Cancer Chemotherapeutic Drug Research inChina
13 Doxorubicin Cardiotoxicity Revisited: ROS Versus Top2
14 Biochemistry and Pharmacology of Human ABCC1/MRP1 and ItsRole in Detoxification and in Multidrug Resistance of CancerChemotherapy
15 The Role of Traditional Chinese Medicine in ClinicalOncology
16 Effect of Arsenic Trioxide on Acute Promyelocytic Leukemiaand Glioma: Experimental Studies, Clinical Applications, andPerspectives
17 Recent Advances in Nasopharyngeal Carcinoma Research and ItsPathogenesis
18 EsophageaI Carcinoma
19 Research on Colorectal Cancer in China
20 Molecular and Cellular Characteristics of Small CeH LungCancer: Implications for Molecular-Targeted Cancer Therapy
21 Possibility to Partly Win the War Against Cancer
About the Editors
